For example, seven people (about 24 percent) on liraglutide reported worse mood, but so did eight (roughly 26 percent) on placebo
Clinical trials with semaglutide have demonstrated significant potential to treat diseases of the brain, liver, heart, vascular system (veins and arteries), lungs, bones, skin, and kidneys [1,4], and this class of drugs also shows promise for treating arthritis [1,5]
Silva specializes in evidence-based weight management, including GLP-1 and GIP therapies such as semaglutide and tirzepatide
Local injection site reactions are the most common form of hypersensitivity and may include: Erythema, swelling, or induration at the injection site Pruritus or burning sensation localized to the area Persistent pain or tenderness beyond typical injection discomfort Development of nodules or persistent lumps These reactions typically occur within hours to days of injection and may resolve spontaneously, though persistent or worsening symptoms warrant medical evaluation
Menstrual cycle changes are reported by approximately 20 percent of female researchers, likely related to the hormonal shifts that accompany rapid weight loss rather than a direct effect of the medication
